Adc Therapeutics Sa
(ADCT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 494,416 | 348,593 | 0 | N/A | 0 |
| Other current assets | 12,003 | 10,532 | 0 | 0 | 0 |
| TOTAL | $506,419 | $359,125 | $0 | $N/A | $0 |
| Non-Current Assets | |||||
| PPE Net | 1,502 | 1,260 | N/A | N/A | N/A |
| Intangibles | 9,814 | 8,825 | 0 | 0 | 0 |
| Other Non-Current Assets | 3,791 | 4,632 | 0 | 0 | 0 |
| TOTAL | $15,107 | $14,717 | $N/A | $N/A | $N/A |
| Total Assets | $521,526 | $373,842 | $0 | $N/A | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,642 | 3,113 | 0 | N/A | 0 |
| Accounts payable and accrued liabilities | 6,146 | 6,797 | 0 | 0 | 0 |
| Other current liabilities | 22,633 | 20,211 | 0 | N/A | 0 |
| TOTAL | $32,563 | $31,368 | $0 | $N/A | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 112,904 | 146,172 | 0 | 0 | 0 |
| TOTAL | $112,904 | $146,172 | $N/A | $N/A | $N/A |
| Total Liabilities | $145,467 | $177,540 | $0 | $N/A | $0 |
| Shareholders' Equity | |||||
| Common Shares | 6,314 | 5,795 | 0 | N/A | 0 |
| Retained earnings | -638,930 | -618,602 | 0 | N/A | 0 |
| Other shareholders' equity | 27,643 | 16,504 | 0 | 0 | 0 |
| TOTAL | $376,059 | $196,302 | $0 | $N/A | $0 |
| Total Liabilities And Equity | $521,526 | $373,842 | $0 | $0 | $0 |